2 HIV Vaccine Trials Show Proof of Concept for Pathway to Broadly Neutralizing Antibodies
The Scripps Research Institute
North American and African clinical trials led by Scripps Research, IAVI, and additional collaborators across the US and Africa mark progress toward an effective HIV vaccine